Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

All news

Show

From To
Trial Pairs PrEP With Behavioral Intervention to Prevent HIV in Drug Users

Yale University investigators are leading a trial that is testing a bio-behavioral intervention’s ability to improve pre-exposure prophylaxis (PrEP) adherence and reduce the risk of HIV acquisition in individuals with opioid dependency, a population experiencing new outbreaks of HIV.

Published
15 July 2019
From
Contagion Live
These Women Are Forgotten HIV Warriors

The legacy of straight women in the early fight against the AIDS epidemic should not be underrated.

Published
15 July 2019
From
HIV Plus
“Marseilles Bears a Heavy Stigma of Drug Trafficking and Use” – An Interview with Beatrice Stambul

The city of Marseilles decided to open its first drug consumption room. Read our interview with Beatrice Strambul, who has been in the forefront of the harm reduction movement in France since the 1990s.

Published
15 July 2019
From
Drug Reporter
Are 2 million bottles of PrEP an empty gesture?

Gilead should either commit to providing all the doses of PrEP required for everyone who would benefit or open the market up to a range of generic manufacturers.

Published
15 July 2019
From
The Lancet HIV
J&J’s Quest for Elusive HIV Vaccine Is Poised for Major Test

Johnson & Johnson is preparing to test an experimental HIV vaccine in the U.S. and Europe in a move toward developing the first immunization against the deadly disease after decades of frustration.

Published
15 July 2019
From
Bloomberg
Professor Chloe Orkin: Chair of the British HIV Association

Alice talks to Professor Chloe Orkin, Chair of the British HIV Association, and a medical activist committed to the U=U campaign.

Published
15 July 2019
From
Audioboom / The Dorothy Project
Trial Pairs PrEP With Behavioral Intervention to Prevent HIV in Drug Users

Yale University investigators are leading a trial that is testing a bio-behavioral intervention’s ability to improve pre-exposure prophylaxis (PrEP) adherence and reduce the risk of HIV acquisition in individuals with opioid dependency, a population experiencing new outbreaks of HIV.

Published
12 July 2019
From
Contagionlive.com
How Australia Could Almost Eradicate H.I.V. Transmissions

It took universal health care, political will and a health campaign designed to terrify the public, but nearly four decades into the H.I.V. crisis, Australian researchers say the country is on a path toward making transmissions of the virus vanishingly rare.

Published
12 July 2019
From
New York Times
Scripps Research-led consortium receives $129 million NIH award to bring new HIV vaccination approach into clinical testing

The candidate vaccine products are designed to be administered in multiple stages to induce immune system proteins called broadly neutralizing antibodies (bnAbs). In multiple animal studies, bnAbs have been shown to provide long-lasting protection against exposure to multiple HIV strains.

Published
12 July 2019
From
Scripps Institute
Meet the UNAIDS leadership contenders

Opinions vary on who should take the top job from a diverse shortlist that includes former politicians, medical scientists, and an NGO leader.

Published
11 July 2019
From
Devex

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.